Combination DMARD treatment with parenteral gold and methotrexate

Clinical and Experimental Rheumatology

Volumn 17, Issue 6 SUPPL. 18, 1999, Pages

  Rau, R ^a  

^a Evangelisches Fach krankenhaus Ratingen   (Germany)

Author keywords

Combination DMARD treatment; Gold sodium thiomalate; Long term observational study; Methotrexate; Rheumatoid arthritis

Indexed keywords

AUROTHIOMALATE; C REACTIVE PROTEIN; GOLD SALT; METHOTREXATE;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; GOLD SODIUM THIOMALATE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032745849     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. FRIES JF, WILLIAMS CA, RAMEY D, BLOCH DA: The relative toxicity of disease modifying antirheumatic drugs. Arthritis Rheum 1993; 36: 297-306.
2. FELSON DT, ANDERSON JJ, MEENAN R: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Arthritis Rheum 1990; 33: 1449-61.
3. Cooperation Clinics Committee of the American Rheumatism Association: A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 1973; 353-8.
4. SIGLER JW, BLUHM GB, DUNCAN H, et al.: Gold salts in the treatment of rheumatoid arthritis. Am Intern Med 1974; 60: 21-6.
5. CATS A: A multicenter controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage. Agents Actions 1976; 6: 355-65.
6. LUUKKAINEN R, ISOMÄKI H, KAJANDER A: Effect of gold treatment on the progression of erosions in RA patients. Scand J Rheumatol 1977; 6: 123-7.
7. LUUKKAINEN R, ISOMÄKI H, KAJANDER A: Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol 1977; 6: 189-92.
8. LUUKKAINEN R: Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect on radiographical changes and on the optimal time of initiation of therapy. Scand J Rheumatol 1980; 34: 1.
9. LARSEN A, HORTON J, HOWLAND C: The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: An x-ray analysis. Clin Rheumatol 1984; 3 (Suppl. 1): 97-104,
10. BUCKLAND-WRIGHT JC, CLARKE GS, CHIKANZA IC, GRAHAME R: Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol 1993; 20: 243-7.
11. SANY J, KALISKI S, COURET M, et al.: Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol 1990; 17: 1636-41.
12. DROSOS AA, KARANTANAS AH, PSYCHOS D, et al.: Can treatment with methotrexate influence the radiological progression of rheumatoid arthritis? Clin Rheumatol 1990; 9: 342-5.
13. NORDSTROM DM, WEST SG, ANDERSEN PA, SHARP JT: Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med 1987; 107: 797-801.
14. REYKDAL S, STEINSSON K, SIGURJONSSON K, BREKKAN A: Methotrexate treatment of rheumatoid arthritis: Effects on radiological progression. Scand J Rheumatol 1989; 18: 221-6.
15. RAU R, HERBORN G, KARGER T, WERDIER D: Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. Arthritis Rheum 1991; 10: 1236-44.
16. MORRASUT T, GOLDSTEIN R, CYR M, et al.: Gold-sodium-thiomalat compared to low-dose methotrexate in the treatment of rheumatoid arthritis - A randomised double-blind 26-week trial. J Rheumalol 1989; 16: 302-6.
17. SUAREZ-ALMAZOR ME, FITZGERALD A, GRACE M, RUSSELL AS: A randomised controlled trial of parenteral methotrexate compared with sodium aurothiomalate. J Rheumatol 1988; 15: 753-6.
18. RAU R, HERBORN G, KARGER T, BLECH-SCHMIDT J: A double blind randomised parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol 1991; 18: 328-33.
19. RAU R, HERBORN G, MENNINGER H, BLECH-SCHMIDT J: Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12-month data of a double-blind parallel study of 174 patients. Br J Rheumatol 1997; 36: 345-52.
20. MENNINGER H, HERBORN G, BLECH-SCHMIDT J, RAU R: A 36-month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis. Br J Rheumatol 1998; 37: 1060-8.
21. SANDER O, HERBORN G, BOCK E, RAU R: Prospective six-year follow-up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate. Ann Rheum Dis 1999; 58: 281-7.
22. RAU R, HERBORN G, MENNINGER H, SANGHA O: Progression in early erosive rheumatoid arthritis: 12-month results from a randomised controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 1998; 37: 1220-6.
23. FURST DE: Clinical pharmacology of combination DMARD therapy in rheumatoid arthritis. J Rheumatol 1996; 23 (Suppl. 44): 86-90.
24. RAU R, SCHLEUSSER B, HERBORN G, KARGER T: Long term treatment of destructive rheumatoid arthritis with methotrexate. J Rheumatol 1997; 24: 1881-9.
25. RAU R, SCHLEUSSER B, HERBORN G, KARGER T: Long-term combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy. J Rheumatol 1998; 25: 1485-92.
26. ROPES WN, BENNETT GA, COBB S, JACOX R, JESSAR RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175-6.
27. WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization, Geneva, 1979.
28. RAU R, WASSENBERG S, HERBORN G: Can methotrexate reduce the renal toxicity of parenteral gold? J Rheumatol 1993; 20: 759-61.
29. PINCUS T, STEIN M: What is the best source of useful data on the treatment of rheumatoid arthritis: Clinical trials, clinical observations, or clinical protocols? J Rheumatol 1995; 22: 1611-7.
30. FELSON DT, ANDERSON JJ, MEENAN RF: The efficacy and toxicity of combination therapy in rheumatoid arthritis. Arthritis Rheum 1994; 37: 1487-91.
31. DAWES PT, TUNN EJ, FOWLER PD, SCOTT DL: Combination therapy in rheumatoid arthritis. Br J Rheumatol 1984; 41: 28-35.
32. KLIPPEL JH: Winning the battle, losing the war? Another editorial about rheumatoid arthritis (Editorial). J Rheumatol 1990; 17: 1118-22.
33. BOERS M, RAMSDEN M: Long-acting drug combinations in rheumatoid arthritis: A formal overview. J Rheumatol 1991; 18: 316-24.
34. SCOTT DL, SYMMONS DPM, COULTON BL, POPERT AJ: Long-term outcome of treating rheumatoid arthritis: Results after 20 years. Lancet 1987; 337; 1108-11.